MALARIA ELIMINATION THROUGH ASYMPTOMATIC DIAGNOSIS CAMPAIGNS

THE PROBLEM

THE CASE FOR MALARIA ERADICATION
Damaged Public Health

Malaria is an infectious disease of the most vulnerable that affected

229 million people

and killed

409'000 people

67%

were children under the age of five

Impoverished Community

Malaria is among

the reasons for

lost economic growth

, particularly for low-income countries.

An example:

12

billion

the annual lost GDP caused by malaria in Africa

also the number for

the global annual direct costs of malaria,

including illness, treatment and premature deaths

THE CASE FOR ASYMPTOMATIC DIAGNOSIS

60

of malaria cases are asymptomatic.

20-50

of onward tranmission are accounted by asymptomatic cases, which makes malaria elimination in a region near impossible.

However,

current malaria diagnostic

technologies on the market

(

Malaria Rapid Diagnostic Tests (mRDTs)

microscopy

)

are not designed to detect asymptomatic carriers.

Therefore,

global agendas on malaria eradication cannot yet underline the need for asymptomatic screening 

due to the current lack of an available tool.

 
 

HOW OUR CAMPAIGN WORKS

01

INCENTIVIZE & EDUCATE

02

SCREENING
USING OUR DIAGNOSTIC TOOLKIT

03

TREATMENT & DATA COLLECTION

Raise awareness of the importance of malaria asymptomatic screening and improve general health literacy within the local community in regard to malaria elimination through our collaboration with local health organizations.

Technical training for local health practitioners on the use of our novel malaria diagnostic toolkit.

All asymptomatic diagnoses will be done using Hemolytics' malaria diagnostic toolkit with a dual approach: active case detection (ACD) and reactive case detection (RACD).

Detected asymptomatic carriers of the malaria parasites will be treated accordingly.

Data will be collected to evaluate the impact of asymptomatic screening in eliminating malaria.

MEET HEMOLYTICS

OUR STORY

Hemolytics is a deep-tech impact start-up based in the bilingual city of Fribourg, Switzerland. Originally a research project at the Adolphe Merkle Institute at the University of Fribourg, Hemolytics has grown into a spin-off with a pre-founding team that is currently planning for Hemolytics' foundation at the end of summer 2021. The company's mission is to bring Hemolytics' life-saving asymptomatic diagnostic campaigns and technology to as many underserved communities as possible.

OUR VISION

We aim to demonstrate the importance of asymptomatic screening in the arsenal of tools to fight malaria, which will put it on WHO’s official global agenda for malaria eradication. This will pave ways for us as well as other innovators that share the mutual goal of removing this ancient disease from our world once and for all.

OUR TEAM

We are a multidisciplinary team of five changemakers who are inspired to create a lasting social impact through knowledge-based innovation and entrepreneurship (click on the images for more details).

Behind the pre-founding team is our board of advisors, who have been guiding us with their scientific insight, industry experience, and more importantly, a strong belief in Hemolytics (click on the images for more details).

OUR MILESTONES (HIGHLIGHTS)

2016

19th May: Patent application

OUR TIMELINE

2021

  • Seed round funding

  • September: Incorporate Hemolytics SA

 
 
 

HELP US END MALARIA!

We'll get right to the point: We're asking you to help support Hemolytics' asymptomatic screening campaigns.
Your support can be in any forms: financial sponsorship to run a campaign, a supply of antimalarial treatments for an entire campaign, connections to local community leaders and health practitioners where our campaigns are needed, and more.
If you believe that you can support us, please let us know by filling in the form.
LINKS
ABOUT

Dr. Jonas Pollard

Founder, CEO & Co-Inventor

jonas.pollard@hemolytics.ch

Lan Tran

All-round Business Developer

lan.tran@hemolytics.ch

 

Tel: +41 26 300 9254

Adolphe Merkle Institute

Chemin des Verdiers 4

1700 Fribourg

Switzerland

SOCIAL
  • White LinkedIn Icon
  • White Facebook Icon

© 2021 by Hemolytics